NanoViricides Inc. (NNVC)

[leifsmith]

We may be surprised at the price of Flucide when it hits the market. The first buyers will be in a position to pay a high price and still save a lot of money over their current treatment costs.

The enormous mountain of revenue to be gotten from sales of an effective drug against flu can be estimated by reviewing the history of Tamiflu.

Currently the future revenues from Flucide are being discounted based mostly on industry averages of success rates in human trials. There are many reasons why this discount is probably much too high, i.e. many ways in which Flucide (and our other viricides) differ remarkably from a typical drug.